Clinical outcomes of low-dose pharmacokinetic-guided extended half-life versus low-dose standard half-life factor VIII concentrate prophylaxis in haemophilia A patients.
Arunothai RakmanothamChatphatai MoonlaDarintr SosothikulPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)
gov NCT05281185.